OAC
AGIO icon

OMERS Administration Corp’s Agios Pharmaceuticals AGIO Stock Holding History

OMERS Administration Corp’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,200
Closed -$450K – 1045
2025
Q3 		$450K Buy
+11,200
New +$421K ﹤0.01% 766
2016
Q4 		– Sell
-5,400
Closed -$285K – 317
2016
Q3 		$285K Buy
5,400
+400
+8% +$17.4K 0.01% 541
2016
Q2 		$209K Buy
+5,000
New +$247K ﹤0.01% 540

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

OMERS Administration Corp's AGIO Position: Q4 2025 in Review

OMERS Administration Corp sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 11,200 shares — an estimated $450K sold.

OMERS Administration Corp first reported a position in AGIO in Q2 2016 and held it in 3 quarters. The position peaked at $450K in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • OMERS Administration Corp reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 11,200 Agios Pharmaceuticals shares in Q4 2025, an estimated $450K.
  • OMERS Administration Corp first reported a position in Agios Pharmaceuticals in Q2 2016 and held it in 3 quarters.
  • OMERS Administration Corp's Agios Pharmaceuticals position peaked at $450K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.